Jan Van Elslande

1.4k total citations
24 papers, 764 citations indexed

About

Jan Van Elslande is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Jan Van Elslande has authored 24 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Jan Van Elslande's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (7 papers). Jan Van Elslande is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (7 papers). Jan Van Elslande collaborates with scholars based in Belgium, United States and Myanmar. Jan Van Elslande's co-authors include Pieter Vermeersch, Marc Van Ranst, Emmanuel André, Katrien Lagrou, Els Houben, Melissa Depypere, Stefanie Desmet, Piet Maes, Lies Laenen and Tony Wawina-Bokalanga and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Immunology and Transplantation.

In The Last Decade

Jan Van Elslande

21 papers receiving 747 citations

Peers

Jan Van Elslande
Susan M Rattigan United States
Matthew Tate United Kingdom
Ollie Lloyd United Kingdom
Jenna Schafers United Kingdom
David Leeman United Kingdom
Olha Puhach Switzerland
Niko Kohmer Germany
Samuel Rigby United Kingdom
Susan M Rattigan United States
Jan Van Elslande
Citations per year, relative to Jan Van Elslande Jan Van Elslande (= 1×) peers Susan M Rattigan

Countries citing papers authored by Jan Van Elslande

Since Specialization
Citations

This map shows the geographic impact of Jan Van Elslande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Van Elslande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Van Elslande more than expected).

Fields of papers citing papers by Jan Van Elslande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Van Elslande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Van Elslande. The network helps show where Jan Van Elslande may publish in the future.

Co-authorship network of co-authors of Jan Van Elslande

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Van Elslande. A scholar is included among the top collaborators of Jan Van Elslande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Van Elslande. Jan Van Elslande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elslande, Jan Van, Pieter Vermeersch, Glynis Frans, et al.. (2024). IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial Infections. The Journal of Applied Laboratory Medicine. 9(6). 977–989. 1 indexed citations
2.
Dedeene, Lieselot, et al.. (2024). An artificial intelligence-driven support tool for prediction of urine culture test results. Clinica Chimica Acta. 562. 119854–119854. 6 indexed citations
3.
Delanghe, Joris, et al.. (2024). Interpretation of TSH results can be improved by reference values fluctuating in time. Hormone Molecular Biology and Clinical Investigation. 46(1). 21–26. 1 indexed citations
4.
Delanghe, Joris, et al.. (2024). Colorimetric correcting for sample concentration in stool samples. Clinical Chemistry and Laboratory Medicine (CCLM). 63(3). 581–586.
5.
Bossuyt, Xavier, Jean‐Baptiste Vulsteke, Jan Van Elslande, et al.. (2023). Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13). Autoimmunity Reviews. 22(4). 103288–103288. 4 indexed citations
6.
Frans, Glynis, Jan Van Elslande, Louis Boon, et al.. (2023). Complementarity determining regions in SARS-CoV-2 hybrid immunity. Frontiers in Immunology. 14. 1050037–1050037.
7.
Elslande, Jan Van, et al.. (2022). Three Cases of Atypical Pneumonia with Chlamydia psittaci: The Role of Laboratory Vigilance in the Diagnosis of Psittacosis. Pathogens. 12(1). 65–65. 7 indexed citations
8.
Elslande, Jan Van, et al.. (2022). IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination. Diagnostic Microbiology and Infectious Disease. 102(4). 115638–115638. 6 indexed citations
9.
Elslande, Jan Van, Matthijs Oyaert, Natalie Lorent, et al.. (2022). Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection. Diagnostic Microbiology and Infectious Disease. 103(1). 115659–115659. 54 indexed citations
10.
11.
Elslande, Jan Van, Gijs Van Pottelbergh, Lode Godderis, et al.. (2022). IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers. Frontiers in Immunology. 13. 909910–909910. 14 indexed citations
12.
Elslande, Jan Van, Matthijs Oyaert, Marc Van Ranst, et al.. (2021). Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. Journal of Clinical Virology. 136. 104765–104765. 92 indexed citations
13.
Elslande, Jan Van, Michel R. Langlois, Pieter Vermeersch, et al.. (2021). Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample. Biochemia Medica. 31(2). 363–371. 3 indexed citations
14.
Verbeek, Jef, Pieter Vermeersch, Jan Van Elslande, et al.. (2021). Liver or Kidney Transplantation After SARS-CoV-2 Infection: Prevalence, Short-term Outcome, and Kinetics of Serum IgG Antibodies. Transplantation. 106(4). 862–868. 2 indexed citations
15.
Elslande, Jan Van, Pieter Vermeersch, Tony Wawina-Bokalanga, et al.. (2020). Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.. Clinical Infectious Diseases. 354. 85 indexed citations
16.
Elslande, Jan Van, Els Houben, Melissa Depypere, et al.. (2020). Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clinical Microbiology and Infection. 26(8). 1082–1087. 186 indexed citations
17.
Elslande, Jan Van, Stijn Jonckheere, Eric Van Wijngaerden, et al.. (2020). Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clinical Microbiology and Infection. 26(11). 1557.e1–1557.e7. 107 indexed citations
18.
Buntinx, Frank, Peter Claes, Jan Y. Verbakel, et al.. (2020). Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020. Acta Clinica Belgica. 77(2). 295–300. 11 indexed citations
19.
Carlier, Laurence, Steffen Rex, Thomas Vanassche, et al.. (2020). Münchhausen Syndrome: A Case Report of an Unusual Cause of Vitamin K Antagonist Intoxication. A&A Practice. 14(6). e01189–e01189.
20.
Cuypers, Lize, Jan Van Elslande, Stijn Wouters, et al.. (2020). Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center. Journal of the American Medical Informatics Association. 27(8). 1293–1299. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026